Paul-Peter Tak

Paul-Peter Tak is the founder of Sitryx Therapeutics Ltd., founded in 2016, serving as Director.
Dr. Tak is also the founder of MeiraGTx Netherlands BV..
Dr. Tak is President, Chief Executive Officer & Director at Candel Therapeutics, Inc. since 2020.
Dr. Tak is Chairman at Citryll BV since 2023.
Dr. Tak is Director at Levicept Ltd. since 2018.
Dr. Tak is Trustee at The Kennedy Trust for Rheumatology Research.
Formerly, Dr. Tak was President & Chief Executive Officer at Tempero Pharmaceuticals, Inc. from 2012 to 2015.
Dr. Tak was President & Chief Executive Officer at Senda Biosciences, Inc. from 2018 to 2020.
Dr. Tak was Director at ViiV Healthcare Ltd. from 2015 to 2018.
Dr. Tak was Director at Galvani Bioelectronics Ltd. from 2016 to 2018.
Dr. Tak was Director at Omega Therapeutics, Inc. from 2018 to 2020.
Dr. Tak was Chief Immunology Officer & Senior Vice President at GSK Plc from 2011 to 2018.
Dr. Tak was Venture Partner at Flagship Pioneering, LLC from 2018 to 2020.
Dr. Tak was Clinical Associate Professor at the University of California San Diego from 1999 to 2004.
Dr. Tak was Professor at the University of Amsterdam from 1999 to 2011.
Dr. Tak earned doctorates from Vrije Universiteit Amsterdam and the University of Leiden.